[1]
|
Bruno, M.G. and McPherson Jr., S.D. (1949) Harada’s Disease. American Journal of Ophthalmology, 32, 513-522. https://doi.org/10.1016/0002-9394(49)90876-4
|
[2]
|
Shivaram, S., Nagappa, M., Seshagiri, D.V., et al. (2021) Vogt-Koyanagi-Harada Syndrome—A Neurologist’s Perspective. Annals of Indian Academy of Neurology, 24, 405-409. https://doi.org/10.4103/aian.AIAN_405_20
|
[3]
|
Joye, A. and Suhler, E. (2021) Vogt-Koyanagi-Harada Disease. Current Opinion in Ophthalmology, 32, 574-582. https://doi.org/10.1097/ICU.0000000000000809
|
[4]
|
Sugita, S., Takase, H., Kawaguchi, T., et al. (2007) Cross-Reaction between Tyrosinase Peptides and Cytomegalovirus Antigen by T Cells from Patients with Vogt-Koyanagi-Harada Disease. International Ophthalmology, 27, 87-95. https://doi.org/10.1007/s10792-006-9020-y
|
[5]
|
Ye, Z., Wu, C., Zhang, N., et al. (2020) Altered Gut Microbiome Composition in Patients with Vogt-Koyanagi-Harada Disease. Gut Microbes, 11, 539-555. https://doi.org/10.1080/19490976.2019.1700754
|
[6]
|
Ruokonen, P.C., Metzner, S., Ucer, A., Torun, N., Hofmann, J. and Pleyer, U. (2010) Intraocular Antibody Synthesis against Rubella Virus and Other Microorganisms in Fuchs’ Heterochromic Cyclitis. Graefe’s Archive for Clinical and Experimental Ophthalmology, 248, 565-71. https://doi.org/10.1007/s00417-009-1239-7
|
[7]
|
Rao, N.A., Sukavatcharin, S. and Tsai, J.H. (2007) Vogt-Koyanagi-Harada Disease Diagnostic Criteria. International Ophthalmology, 27, 195-199. https://doi.org/10.1007/s10792-006-9021-x
|
[8]
|
Tian, S., Yao, J., Wang, J., et al. (2021) [Autofluorescence Combined with Spectral Domain Optical Coherence Tomography for Diagnosis and Follow-Up of Acute Vogt-Koyanagi-Harada Disease. Journal of Southern Medical University, 41, 135-40.
|
[9]
|
Chen, L., Chang, R., Pan, S., et al. (2020) Plasma Metabolomics Study of Vogt-Koyanagi-Harada Disease Identifies Potential Diagnostic Biomarkers. Experimental Eye Research, 196, Article ID: 108070. https://doi.org/10.1016/j.exer.2020.108070
|
[10]
|
Dinges, S., Hohm, A., Vandergrift, L., et al. (2019) Cancer Metabolomic Markers in Urine: Evidence, Techniques and Recommendations. Nature Reviews Urology, 16, 339-362. https://doi.org/10.1038/s41585-019-0185-3
|
[11]
|
Schmidt, C. (2009) Urine Biomarkers May Someday Detect Even Distant Tumors. Journal of the National Cancer Institute, 101, 8-10. https://doi.org/10.1093/jnci/djn482
|
[12]
|
Li, M., Zhao, M. and Gao, Y. (2014) Changes of Proteins Induced by Anticoagulants Can Be More Sensitively Detected in Urine Than in Plasma. Science China Life Sciences, 57, 649-656. https://doi.org/10.1007/s11427-014-4661-y
|
[13]
|
Nicholson, J., Lindon, J. and Holmes, E. (1999) “Metabonomics”: Understanding the Metabolic Responses of Living Systems to Pathophysiological Stimuli via Multivariate Statistical Analysis of Biological NMR Spectroscopic Data. Xenobiotica: The Fate of Foreign Compounds in Biological Systems, 29, 1181-1189. https://doi.org/10.1080/004982599238047
|
[14]
|
陈琳. 血浆代谢组学分析Vogt-小柳原田综合征的潜在诊断标志物[D]: [硕士学位论文]. 重庆: 重庆医科大学, 2020.
|
[15]
|
Hu, Y., Hu, Y., Xiao, Y., et al. (2020) Genetic Landscape and Autoimmunity of Monocytes in Developing Vogt-Koyanagi-Harada Disease. Proceedings of the National Academy of Sciences of the United States of America, 117, 25712-25721. https://doi.org/10.1073/pnas.2002476117
|
[16]
|
Takayama, K., Obata, H. and Takeuchi, M. (2020) Efficacy of Adalimumab for Chronic Vogt-Koyanagi-Harada Disease Refractory to Conventional Corticosteroids and Immunosuppressive Therapy and Complicated by Central Serous Chorioretinopathy. Ocular Immunology and Inflammation, 28, 509-512. https://doi.org/10.1080/09273948.2019.1603312
|
[17]
|
Hosoda, Y., Hayashi, H. and Kuriyama, S. (2015) Posterior Subtenon Triamcinolone Acetonide Injection as a Primary Treatment in Eyes with Acute Vogt-Koyanagi-Harada Disease. The British Journal of Ophthalmology, 99, 1211-1214. https://doi.org/10.1136/bjophthalmol-2014-306244
|
[18]
|
Park, J.G., Callaway, N.F., Ludwig, C.A., et al. (2020) Intravitreal Methotrexate and Fluocinolone Acetonide Implantation for Vogt-Koyanagi-Harada Uveitis. American Journal of Ophthalmology Case Reports, 19, Article ID: 100859. https://doi.org/10.1016/j.ajoc.2020.100859
|
[19]
|
Chen, Z., Zhong, Z., Zhang, W., et al. (2020) Integrated Analysis of Key Pathways and Drug Targets Associated with Vogt-Koyanagi-Harada Disease. Frontiers in Immunology, 11, Article ID: 587443. https://doi.org/10.3389/fimmu.2020.587443
|